Postmortem study of proliferative glomerulonephritis associated with human systemic lupus has previously shown that an antigen related to mammalian type C RNA viral core (p30) (1, 2). We attempt to extend this finding by examining the immune deposits for the presence of a type C virus antibody. Human Igs were sequentially eluted from the lupus glomerular immune deposits and were assayed for anti-p3O antibody activity against purified viral p30 protein antigens of mammalian type C viruses. A sensitive enzymoimmunoassay was developed for detection and measurement of anti-p30 antibodies. Human Igs showing specific anti-p30 antibody activity by this assay were eluted from the glomerular immune deposits in two patients with lupus proliferative glomerulonephritis known from previous work to contain deposits of viral p30-related antigen in the same tissue lesions. This investigation adds support for the hypothesis, stemming from studies of the murine model of systemic lupus (3, 4) , that expression of type C viral antigen may be involved in the multifactorial pathogenesis of proliferative glomerulonephritis associated with human systemic lupus.
nephritis who have deposits of viral p30-related antigen in the same tissue lesions. This study adds support for the hypothesis that expression of type C viral antigen may be involved in the multifactorial pathogenesis of proliferative glomerulonephritis associated with human systemic lupus. Human systemic lupus erythematosus (SLE) is a multisystemic autoimmune syndrome of unknown etiology and multifactorial pathogenesis. Postmortem study of a subset of systemic lupus associated with proliferative glomerulonephritis has shown that an antigen related to the interspecies determinants of mammalian type C RNA viral core (p30) proteins is located in the renal glomerular lesions with human immunoglobulins (Igs) in an immune-complex pattern of deposition (1, 2) . We attempt to extend this finding by examining the immune deposits for the presence of a type C virus antibody. Human Igs were sequentially eluted from the lupus glomerular immune deposits and were assayed for anti-p3O antibody activity against purified viral p30 protein antigens of mammalian type C viruses. A sensitive enzymoimmunoassay was developed for detection and measurement of anti-p30 antibodies. Human Igs showing specific anti-p30 antibody activity by this assay were eluted from the glomerular immune deposits in two patients with lupus proliferative glomerulonephritis known from previous work to contain deposits of viral p30-related antigen in the same tissue lesions. This investigation adds support for the hypothesis, stemming from studies of the murine model of systemic lupus (3, 4) , that expression of type C viral antigen may be involved in the multifactorial pathogenesis of proliferative glomerulonephritis associated with human systemic lupus.
MATERIALS AND METHODS
Viruses. The following viruses purified by twice banding in sucrose gradients were provided by S. A. Mayyasi and K. A. Antisera. The following monospecific goat antisera produced against purified viral p30 proteins were used: anti-R-MuLV p30, anti-RD-114 p28, and anti-SSAV p28 serum obtained from R. Wilsnack (Huntingdon Research Center) through the courtesy of J. Gruber, National Cancer Institute; and anti-FeLV p27 serum kindly provided by S. Oroszlan (Flow Laboratories, Inc.). Normal goat serum and fetal calf serum were obtained from commercial sources.
Elution of Human SLE Kidney Igs. The starting materials were human renal tissues obtained at postmortem examination of three patients with SLE described elsewhere (1, 2) . Briefly summarized, the duration of the disease in patients 1 and 2 was %/2 and 2 years, respectively; the SLE was associated with diffuse proliferative glomerulonephritis and showed typical glomerular deposits of host Ig and, less extensively, of type C viral p30-like antigen; the duration of the disease in patient 3 was 15 years; the SLE was not associated' with proliferative-type glomerulonephritis and showed glomerular deposits of host Ig but no detectable p30-like antigen. In the latter respect, patient 3 served as a negative control for the other two patients. The renal tissue was minced and homogenized in cold isotonic saline and the insoluble sediment containing glomeruli was thoroughly Abbreviations: MuLV, murine leukemia virus; FeLV, feline leukemia virus; SSAV, simian sarcoma associated virus; Type C Viral p30 Antibody Activity of Reference Goat Anti-30 Sera Determined-by Enzymoimmunoassay. The straight-line portion of the titration curve of dilutions, logjo(1/D), of reference goat anti-p3O sera against homologous type C viral p3O protein antigens as determined by enzymoimmunoassay and measurement of absorbance at 400 nm for anti-R-MuLV p3O, anti-FeLV p27, and anti-RD-114 p28 sera are given in Fig. 2A . Antibody titers of these antisera against homologous and heterologous viral p30 antigens as determined by enzymoimmunoassay are given in Table 4 as endpoint dilutions giving an absorbance of 0;5, compared to a background of 0.1-0.2 at most. As noted in Table 4 , the log1o titer of anti-R-MuLV p3O serum against R-MuLV p30 antigen was 6.0, against FeLV p27 it was 5.3, and against RD-114 p28 it was 5.0, corresponding to antiserum dilutions of 1,000,000, 200,000, and 100,000, respectively. The loglo titer of anti-RD-114 p28 serum against RD-114 p28 was 4.8 and against R-MuLV p3O or FeLV p27 it was 4.0, corresponding to antiserum dilutions of 60,000 and 10,000, respectively. These Fig. 2B for doubling dilutions from 80 to 1280. This titration curve was parallel to that given by reference goat anti-RD-114 p28 serum against the same RD-114 p28 antigen but, as shown by comparison of Fig. 2 A (19, 22) . The human anti-30 antibody had a titer of 80 against purified RMuLV p30 protein, consistent with weaker crossreaction with a more distantly related type C virus group (16) (17) (18) (19) (20) (21) (22) . Preliminary assays of the antibody activity against SSAV p28 protein also gave a titer of 80 (unpublished work). Detection of autol- (27, (37) (38) (39) .
